Cyclacel Pharmaceuticals Announces Appointment of Mark Kirschbaum, M.D., as Chief Medical Officer

    NEXT STORY
    Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer
    PREV STORY
    Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Care Business in Massachusetts
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Medical Facility of the Future Coming to Clifton Park, NY

    author_avatar
    NASDAQ Market News

    United Arab Emirates Nucleic Acid Testing Market for 100 Assays 2019: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

    author_avatar
    NASDAQ Market News

    Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting

    author_avatar
    NASDAQ Market News